VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
VOLITIONRX LTD
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.17−0.01 (-3.50%)
Close on Oct 19, 2026
- Market cap
- $1.59M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Volitionrx has not reported a dividend
No dividend per share appears in Volitionrx's annual filings since fiscal 2010.